MolAlcule
MolAIcule is an integrated AI–Biology–Chemistry (ABC) company that designs higher-quality drug candidates faster, by training models on multi-omics, structural, and real-world data. The Delaware C-Corporation has two pipeline programs of its own — a neurology asset post-PCC heading into IND-Enabling, and an oncology asset in lead optimization — and the platform is built on USF research into peptidomimetic inhibitor design.